Insights filtered by:

Small and medium-sized enterprises

For SMEs, properly leveraged IP can be a source of revenue, and security for future investment. We understand that cost and time are key considerations when managing an IP portoflio, we give SMEs the guidance and advice they need to commercialise and protect their IP, with a cost-effective IP strategy.

Clear all Small and medium-sized enterprises
Podcasts

The Greenshoots Podcast by Appleyard Lees – commercialising innovation: five golden rules for licensors and licensees when licensing IP

In this episode, Amritjot Jethwa, Head of Commercial IP Contracts, is joined by Chris Hoole, Partner, in providing a quick-fire summary of 5 important factors to consider as a Licensor and as a Licensee when licensing technology, creating the building blocks for the successful commercialisation of IP.

Read more
Directors and IP – getting up close and personal - part 2
Articles

Directors and IP – getting up close and personal – part 2

The UK Supreme Court has provided guidance on the circumstances upon which directors may be personally liable as an accessory to a tort (trade mark infringement is a tortious act) committed by their company.

Read more
1 / 1 – T 176221
Articles

T 1762/21 – Added matter and intermediate generalisations: when are features “inextricably linked”?

Sarah Gibbs discusses a recent decision from the European Patent Office on how intermediate generalisations should be assessed for added matter.

Read more
Articles

Don’t miss out on the EPO’s new fee reductions for micro entities

Getting a patent granted for your innovation can be a costly process. There are, of course, fees associated with the work your patent attorneys do to advise you, to prepare your patent application, and to work with the Patent Office to obtain a granted patent for you. 

Read more
Articles

Biological deposits for patents, the Five “W”s: Why, What, Where, When and Who?

Rachel Mercer discusses how biological deposits can be used to fulfil the requirements of a sufficient disclosure for patent applications involving biological material.

Read more
Podcasts

The Greenshoots Podcast by Appleyard Lees – one year of the Unified Patent Court – what’s been filed? Statistics, three notable cases & commentary

In this episode, Appleyard Lees patent attorneys Kate Hickinson and Edward Rainsford discuss: what has been filed at the UPC so far.

Read more
Articles

Key trends in cell and gene therapy

The Bioindustry Association (BIA) recently published its latest report on the cell and gene therapy sector in the UK, which is a thriving environment for research and development. In this article, trainee patent attorney Chloe Johnson, and patent attorney and associate Claire Devine, provide an update on key trends in this area, and discuss considerations for an effective IP strategy.

Read more
Articles

Glossary of patent terms – part 2 of 3

In this three-part glossary, we lead you through some of the key terminology you may come across when you’re going through the patent process.

Read more
Articles

Plant varieties: Italian Court offers seed of hope to those that fail to claim priority

The mere thought of missing a priority deadline is likely to bring a patent attorney out in a cold sweat but fortunately the world of plant varieties is slightly more lenient as two decisions in Italy highlighted recently.

Read more
Articles

Insect protein innovation on upward trend, despite 2021 slow down

Inside Green Innovation: Progress Report - Third Edition's data shows general upward trend in insect protein innovation, despite 2021 slow down.

Read more
Articles

When benchmarking becomes a little cloudy: Aldi’s success against Thatchers Cider Company Limited

In a much anticipated decision, the High Court has dismissed an infringement and passing off claim by Thatchers against Aldi in relation to Aldi’s use of its get-up on its cloudy lemon cider product.

Read more
1 2 3 4 14 15
Skip to content